These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 1775978)
41. Molecular interrelationships in multidrug resistance (review). Kellen JA Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843 [TBL] [Abstract][Full Text] [Related]
42. Cancer chemotherapy. Carter SK Front Radiat Ther Oncol; 1980; 15():58-65. PubMed ID: 7239187 [No Abstract] [Full Text] [Related]
43. Will there be a future role for radiation in the neo-adjuvant therapy for rectal cancer? Mohiuddin M; Thomas CR Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):643-4. PubMed ID: 21621118 [No Abstract] [Full Text] [Related]
44. Chemotherapy in advanced bladder cancer: a review with emphasis on future studies. Splinter TA Arch Esp Urol; 1990; 43 Suppl 2():215-7. PubMed ID: 2096782 [No Abstract] [Full Text] [Related]
48. [Mechanism of multidrug resistance in human cancers]. Zhang HY Sheng Li Ke Xue Jin Zhan; 1992 Jan; 23(1):30-5. PubMed ID: 1411422 [No Abstract] [Full Text] [Related]
49. Proceedings: The future of cancer chemotherapy. Burchenal JH Proc Natl Cancer Conf; 1972; 7():123-30. PubMed ID: 4764894 [No Abstract] [Full Text] [Related]
50. Tumor cell drug resistance and its reversal. Mansouri A; Henle KJ; Nagle WA; Moss AJ SAAS Bull Biochem Biotechnol; 1990 Jan; 3():91-6. PubMed ID: 1366508 [TBL] [Abstract][Full Text] [Related]
51. [Current emphasis in experimental cancer research and its relation to clinical oncology]. Seeber S Onkologie; 1986 Oct; 9 Suppl 2():14, 17-9. PubMed ID: 3534669 [No Abstract] [Full Text] [Related]
53. [Advances in drug therapy of neoplasms]. Gross R Verh Dtsch Ges Inn Med; 1972; 78():93-105. PubMed ID: 4665784 [No Abstract] [Full Text] [Related]
54. Carcinogenesis and the response of tumours to anticancer drugs. Keith WN; Brown R Anticancer Res; 1991; 11(5):1739-43. PubMed ID: 1768046 [TBL] [Abstract][Full Text] [Related]
55. [Resistance to chemotherapeutic agents in the treatment of cancer. Emphasizing the multiresistant phenotype]. Holte H Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2423-7. PubMed ID: 1926080 [TBL] [Abstract][Full Text] [Related]
56. Genetic and kinetic factors in the drug resistance of micrometastatic disease. Goldie JH Prog Clin Biol Res; 1990; 354A():99-107. PubMed ID: 2247503 [TBL] [Abstract][Full Text] [Related]
57. Cellular maturation and oncogene expression during drug-induced differentiation in vitro: a brief review. Biedler JL; Spengler BA; Ross RA Prog Clin Biol Res; 1990; 354A():287-312. PubMed ID: 2247493 [No Abstract] [Full Text] [Related]
58. [Oncobiogram and its significance in the choice and efficacy of cytostatic therapy]. Savran VR Vopr Onkol; 1983; 29(3):106-13. PubMed ID: 6340347 [No Abstract] [Full Text] [Related]
59. [Drug resistance and implication for therapy]. Tsuruo T Rinsho Ketsueki; 1989 Aug; 30(8):1128-32. PubMed ID: 2574754 [TBL] [Abstract][Full Text] [Related]